Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders

被引:60
作者
Jensen, RT [1 ]
机构
[1] NIDDK, Digest Dis Branch, NIH, Bethesda, MD 20892 USA
来源
PHARMACOLOGY & TOXICOLOGY | 2002年 / 91卷 / 06期
关键词
D O I
10.1034/j.1600-0773.2002.910611.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this paper the possible roles of cholecystokinin (CCK), gastrin, or gastrin-related peptides and their receptors in human gastrointestinal diseases are reviewed. For CCK/CCKA receptors (CCKA-R), the evidence for their proposed involvement in diseases caused by impaired CCK release or CCKA-R mutations, pancreatic disorders (acute/chronic pancreatitis), gastrointestinal motility disorders (gallbladder disease. irritable bowel syndrome), pancreatic tumor growth and satiety disorders, is briefly reviewed. The evidence that has established the involvement of gastrin/CCKB-R in mediating the action of hypergastrinaemic disorders. mediating lipergastrinaemic effects on the gastric mucosa (ECL hyperplasia, carcinoids. parietal cell mass). and acid-peptic diseases. is reviewed. The evidence for their possible involvement in mediating growth of gastric and pancreatic tumours and possible involvement of gastrin-related peptides in colon cancers. is reviewed briefly.
引用
收藏
页码:333 / 350
页数:18
相关论文
共 287 条
[1]   A PILOT CLINICAL-TRIAL OF THE CHOLECYSTOKININ RECEPTOR ANTAGONIST-MK-329 IN PATIENTS WITH ADVANCED PANCREATIC-CANCER [J].
ABBRUZZESE, JL ;
GHOLSON, CF ;
DAUGHERTY, K ;
LARSON, E ;
DUBROW, R ;
BERLIN, R ;
LEVIN, B .
PANCREAS, 1992, 7 (02) :165-171
[2]   A new cause of Zollinger-Ellison syndrome: Non-small cell lung cancer [J].
Abou-Saif, A ;
Lei, JY ;
McDonald, TJ ;
Chakrabarti, S ;
Waxman, IF ;
Shojamanesh, H ;
Schrump, DS ;
Kleiner, DE ;
Gibril, F ;
Jensen, RT .
GASTROENTEROLOGY, 2001, 120 (05) :1271-1278
[3]   GASTROINTESTINAL MOTILITY IN PATIENTS WITH THE IRRITABLE-BOWEL-SYNDROME [J].
ABRAHAMSSON, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 :21-26
[4]   COURSE AND SPONTANEOUS REGRESSION OF ACUTE-PANCREATITIS IN THE RAT [J].
ADLER, G ;
HUPP, T ;
KERN, HF .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1979, 382 (01) :31-47
[5]   INTERACTION OF THE CHOLINERGIC SYSTEM AND CHOLECYSTOKININ IN THE REGULATION OF ENDOGENOUS AND EXOGENOUS STIMULATION OF PANCREATIC-SECRETION IN HUMANS [J].
ADLER, G ;
BEGLINGER, C ;
BRAUN, U ;
REINSHAGEN, M ;
KOOP, I ;
SCHAFMAYER, A ;
ROVATI, L ;
ARNOLD, R .
GASTROENTEROLOGY, 1991, 100 (02) :537-543
[6]   Gallbladder muscle dysfunction in patients with chronic acalculous disease [J].
Amaral, J ;
Xiao, ZL ;
Chen, Q ;
Yu, PR ;
Biancani, P ;
Behar, J .
GASTROENTEROLOGY, 2001, 120 (02) :506-511
[7]  
[Anonymous], SURG ENDOCRINOLOGY C
[8]   Physiological role of cholecystokinin B/gastrin receptor in leptin secretion [J].
Attoub, S ;
Levasseur, S ;
Buyse, M ;
Goïot, H ;
Laigneau, JP ;
Moizo, L ;
Hervatin, F ;
Le Marchand-Brustel, Y ;
Lewin, JMM ;
Bado, A .
ENDOCRINOLOGY, 1999, 140 (10) :4406-4410
[9]   GASTRIN AND THE VAGUS INTERACT IN THE TROPHIC CONTROL OF THE RAT OXYNTIC MUCOSA [J].
AXELSON, J ;
EKELUND, M ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1988, 22 (03) :237-243
[10]   THE ROLE OF GASTRIN AND CHOLECYSTOKININ IN NORMAL AND NEOPLASTIC GASTROINTESTINAL GROWTH [J].
BALDWIN, GS .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (02) :215-232